N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141507 |
| CAS No | NA |
| Mol.F. | C22H25N3O3S |
| Mol.Wt. | 411.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141508 |
| CAS No | NA |
| Mol.F. | C22H25N3O3S |
| Mol.Wt. | 411.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141509 |
| CAS No | 126209-21-0 |
| Mol.F. | C6H7N3O |
| Mol.Wt. | 137.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141510 |
| CAS No | NA |
| Mol.F. | C20H26N6O3 |
| Mol.Wt. | 398.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141511 |
| CAS No | NA |
| Mol.F. | C27H35N9O5S2 |
| Mol.Wt. | 629.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141512 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141513 |
| CAS No | NA |
| Mol.F. | C22H29N7O5S |
| Mol.Wt. | 503.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141514 |
| CAS No | NA |
| Mol.F. | C12H18N4O5S |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141515 |
| CAS No | NA |
| Mol.F. | C21H20ClN5O2S |
| Mol.Wt. | 441.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141516 |
| CAS No | NA |
| Mol.F. | C14H21ClN4O3 |
| Mol.Wt. | 328.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141517 |
| CAS No | NA |
| Mol.F. | C12H16ClN3O3 |
| Mol.Wt. | 285.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141518 |
| CAS No | NA |
| Mol.F. | C12H17ClN4O3 |
| Mol.Wt. | 300.7 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141519 |
| CAS No | NA |
| Mol.F. | C21H21N3O9 |
| Mol.Wt. | 459.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141520 |
| CAS No | NA |
| Mol.F. | C18H14ClFN4O |
| Mol.Wt. | 356.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141521 |
| CAS No | NA |
| Mol.F. | C16H12ClFN4O |
| Mol.Wt. | 330.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141522 |
| CAS No | NA |
| Mol.F. | C15H10Cl2FN3O2 |
| Mol.Wt. | 354.2 |
| INV STATUS | CUSTOM SYNTHESIS |